Comera Life Sciences Holdings, Inc.·5

Feb 14, 5:54 PM ET

Yee John D. 5

5 · Comera Life Sciences Holdings, Inc. · Filed Feb 14, 2023

Insider Transaction Report

Form 5
Period: 2022-12-31
Yee John D.
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-05-19+41,60841,608 total
    Exercise: $0.59Exp: 2031-06-08Common Stock (41,608 underlying)
Footnotes (2)
  • [F1]The shares underlying the option vest in 48 equal monthly installments beginning on June 8, 2021.
  • [F2]This option was issued pursuant to the terms of a business combination agreement involving the issuer and Comera Life Sciences, Inc. in exchange for a comparable option previously issued by such company.

Documents

2 files
  • 5
    form5.xmlPrimary

    ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

  • EX-24

    POWER OF ATTORNEY